《成人原发性免疫性血小板减少症诊断与治疗中国指南（2020年版）》 - Suppr

Suppr

超能文献

[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.

DOI:10.3760/cma.j.issn.0253-2727.2020.08.001

PMID:32942813

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525165/

Abstract

摘要

相似文献

[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].

Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.

[Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021)].

Zhonghua Er Ke Za Zhi. 2021 Oct 2;59(10):810-819. doi: 10.3760/cma.j.cn112140-20210509-00397.

[Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2012)].

Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):975-7.

[Chinese expert consensus on the diagnosis and treatment of thromboembolism in patients with immune thrombocytopenia (2023)].

Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):6-11. doi: 10.3760/cma.j.issn.0253-2727.2023.01.002.

[Recommendation in the diagnosis and treatment of adult primary immune thrombocytopenia].

Zhonghua Nei Ke Za Zhi. 2021 Jun 1;60(6):501-505. doi: 10.3760/cma.j.cn112138-20200714-00670.

[Recommendations for diagnosis and treatment of primary immune thrombocytopenia in children].

Zhonghua Er Ke Za Zhi. 2013 May;51(5):382-4.

2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy.

Chin Med J (Engl). 2022 Apr 20;135(8):887-889. doi: 10.1097/CM9.0000000000002043.

[To standardize the diagnosis and treatment of primary immune thrombocytopenia in children].

Zhonghua Er Ke Za Zhi. 2021 Oct 2;59(10):807-809. doi: 10.3760/cma.j.cn112140-20210814-00669.

[Intensive reading of Recommendations for Diagnosis and Treatment of Primary Immune Thrombocytopenia in Children].

Zhonghua Er Ke Za Zhi. 2013 May;51(5):389-91.

[Thrombocytopenia].

Rev Prat. 2005 Jun 30;55(12):1355-61.

引用本文的文献

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series.

Front Pharmacol. 2025 Aug 26;16:1646837. doi: 10.3389/fphar.2025.1646837. eCollection 2025.

Dose-optimised recombinant human thrombopoietin eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study).

EClinicalMedicine. 2025 Aug 21;87:103459. doi: 10.1016/j.eclinm.2025.103459. eCollection 2025 Sep.

Natural killer cell granule protein 7 contributes to CD8 T cell-mediated platelet apoptosis in immune thrombocytopenia.

Res Pract Thromb Haemost. 2025 Jul 22;9(5):102977. doi: 10.1016/j.rpth.2025.102977. eCollection 2025 Jul.

Comparative analysis of MAIPA assay and PakAuto assay for the diagnosis of primary immune thrombocytopenia.

Clin Exp Med. 2025 Aug 7;25(1):282. doi: 10.1007/s10238-025-01831-8.

Real-world experience of hetrombopag in immune thrombocytopenia treatment: a retrospective cohort study.

Eur J Med Res. 2025 Jul 5;30(1):574. doi: 10.1186/s40001-025-02850-7.

Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications.

Ann Hematol. 2025 Jul;104(7):3537-3551. doi: 10.1007/s00277-025-06482-z. Epub 2025 Jul 1.

Clinical characteristic of isolated thrombocytopenia in patients with bone marrow failure-related germline variants: a retrospective study from a single centre.

Ann Med. 2025 Dec;57(1):2523560. doi: 10.1080/07853890.2025.2523560. Epub 2025 Jun 26.

Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial.

Clin Exp Med. 2025 May 12;25(1):153. doi: 10.1007/s10238-025-01658-3.

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia.

Cancer Rep (Hoboken). 2025 Feb;8(2):e70152. doi: 10.1002/cnr2.70152.

Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports.

Medicine (Baltimore). 2025 Feb 7;104(6):e41449. doi: 10.1097/MD.0000000000041449.

本文引用的文献

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia.

Blood Adv. 2020 Jan 14;4(1):9-18. doi: 10.1182/bloodadvances.2019000868.

American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.

A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.

Am J Hematol. 2019 Dec;94(12):1374-1381. doi: 10.1002/ajh.25646. Epub 2019 Oct 17.

ACOG Practice Bulletin No. 207 Summary: Thrombocytopenia in Pregnancy.

Obstet Gynecol. 2019 Mar;133(3):589-591. doi: 10.1097/AOG.0000000000003101.

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.

Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.

Blood. 2017 Dec 7;130(23):2527-2536. doi: 10.1182/blood-2017-04-748707. Epub 2017 Oct 17.

Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.

Lancet Haematol. 2017 Oct;4(10):e487-e496. doi: 10.1016/S2352-3026(17)30170-9. Epub 2017 Sep 13.

Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.

Surg Today. 2018 Feb;48(2):180-185. doi: 10.1007/s00595-017-1570-2. Epub 2017 Jul 19.

A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy.

Blood. 2017 Aug 31;130(9):1097-1103. doi: 10.1182/blood-2017-01-761262. Epub 2017 Jun 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验